Difference between revisions of "Template:DNA antivirals"

From blackwiki
Jump to navigation Jump to search
imported>Kwamikagami
m (sp.)
(fomivirsen withdrawn)
 
(29 intermediate revisions by 20 users not shown)
Line 1: Line 1:
 
{{Navbox
 
{{Navbox
| name = DNA antivirals
+
| name = DNA antivirals
| title = [[DNA virus]] [[antivirals]] (primarily [[ATC code J05|J05]], also [[ATC code S01#S01AD|S01AD]] and [[ATC code D06#D06BB|D06BB]])
+
| title = [[DNA virus]] [[Antiviral drug|antivirals]] (primarily [[ATC code J05|J05]], also [[ATC code S01#S01AD|S01AD]] and [[ATC code D06#D06BB|D06BB]])
| groupstyle = background:PowderBlue;
+
| state = {{{state<includeonly>|autocollapse</includeonly>}}}
| belowstyle = background:#EE82EE;
+
| listclass = hlist
  
|group1 = [[Baltimore classification|Baltimore I]]
+
| group1 = [[Baltimore classification|Baltimore I]]
|list1   = {{Navbox subgroup
+
| list1 = {{Navbox|child
| groupstyle = background:PowderBlue;
 
  
| group1 = [[Herpesviridae|Herpesvirus]]
+
  | group1 = [[Herpesviridae|Herpesvirus]]
| list1 = {{Navbox subgroup
+
  | list1 = {{Navbox|child
| groupstyle = background:PowderBlue;
 
  
| group1 = DNA-synthesis<BR>inhibitor
+
    | group1 = DNA-synthesis<br />inhibitor
| list1 = {{Navbox subgroup
+
    | list1 = {{Navbox|child
| groupstyle = background:PowderBlue;
 
  
| group1 = [[Thymidine kinase from herpesvirus|TK]] activated
+
      | group1 = [[Thymidine kinase from herpesvirus|TK]] activated
| list1 = {{Navbox subgroup
+
      | list1 = {{Navbox|child
| groupstyle = background:PowderBlue;
 
  
| group1 = [[Purine analogue]]  
+
        | group1 = [[Purine analogue]]
| list1 = ''[[guanine]]'' ([[Aciclovir]]<sup>#</sup>/[[Valacyclovir]], [[Ganciclovir]]/[[Valganciclovir]], [[Penciclovir]]/[[Famciclovir]])<BR>
+
        | list1 =
 +
* ''[[guanine]]'' ([[Aciclovir]]<sup>#</sup>/[[Valaciclovir]]
 +
* [[Ganciclovir]]/[[Valganciclovir]]<sup>#</sup>
 +
* [[Penciclovir]]/[[Famciclovir]])
  
''[[adenine]]'' ([[Vidarabine]], [[Cytarabine]])
+
* ''[[adenine]]'' ([[Vidarabine]])
  
| group2 = [[Pyrimidine analogue]]  
+
        | group2 = [[Pyrimidine analogue]]
| list2 = ''[[uridine]]'' ([[Idoxuridine]], [[Trifluridine]], [[Edoxudine]])<BR>
+
        | list2 =
 +
* ''[[uridine]]'' ([[Idoxuridine]]
 +
* [[Trifluridine]] ([[Trifluridine/tipiracil|+tipiracil]])
 +
* [[Edoxudine]])
  
''[[thymine]]'' ([[Brivudine]])
+
* ''[[thymine]]''
 +
**[[Brivudine]]
 +
**[[FV-100]]<sup>†</sup>
 +
**[[Sorivudine]]
  
}}
+
* ''[[cytosine]]'' ([[Cytarabine]])
  
| group2 = Not TK activated
+
      }}
| list2  = [[Foscarnet]]
 
  
}}
+
      | group2 = Not TK activated
 +
      | list2 =
 +
* [[Foscarnet]]
  
| group2 = Other
+
    }}
| list2  = [[Docosanol]]&nbsp;•  ''[[early protein]]'' ([[Fomivirsen]])&nbsp;•  [[Tromantadine]]
 
  
 +
    | group2 = Other
 +
    | list2 =
 +
* [[Docosanol]]
 +
* [[Maribavir]]<sup>†</sup>
 +
* ''[[early protein]]'' ([[Fomivirsen]]<sup>‡</sup>)
 +
* [[Tromantadine]]
  
}}
+
  }}
  
 +
  | group2 = [[Human papillomavirus|HPV]]/[[Molluscum contagiosum|MC]]
 +
  | list2 =
 +
* [[Imiquimod]]/[[Resiquimod]]
 +
* [[Podophyllotoxin]]
  
| group2 = [[Human papillomavirus|HPV]]/[[Molluscum contagiosum|MC]]
+
  | group3 = [[Vaccinia]]
| list2 = [[Imiquimod]]/[[Resiquimod]]&nbsp;•  [[Podophyllotoxin]]
+
  | list3 =
 +
* ''[[Antiviral drug#Assembly|assembly]]:'' [[Rifampicin]]
  
| group7 = [[Vaccinia]]
+
  | group4 = [[Poxviridae]]
| list7 = ''[[Antiviral_drug#Assembly|assembly]]:'' [[Rifampicin]]
+
  | list4 =
 +
* [[Methisazone]]
 +
* [[Tecovirimat]]
  
| group8 = [[Poxviridae]]
+
  }}
| list8 = [[Methisazone]]
 
  
}}
+
| group2 = [[Hepatitis B]] (VII)
 +
| list2 =
 +
* ''[[Nucleoside analogue]]s/[[Reverse-transcriptase inhibitor#Nucleoside analog reverse transcriptase inhibitors .28NARTIs or NRTIs.29|NARTIs]]:'' [[Entecavir]]<sup>#</sup>
 +
* [[Lamivudine]]
 +
* [[Lobucavir]]<sup>†</sup>
 +
* [[Telbivudine]]
 +
* [[Clevudine]]
  
 +
* ''[[Nucleotide analogue]]s/[[Reverse-transcriptase inhibitor#Nucleotide analog reverse transcriptase inhibitors .28NtARTIs or NtRTIs.29|NtRTIs]]:'' [[Adefovir]]
 +
* [[Tenofovir disoproxil]]
 +
* [[Tenofovir alafenamide]]
  
| group3 = [[Hepatitis B]] (VII)
+
| group3 = Multiple/general
| list3 = ''[[Nucleoside analogue]]s/[[Reverse_transcriptase_inhibitor#Nucleoside_analog_reverse_transcriptase_inhibitors_.28NARTIs_or_NRTIs.29|NARTIs]]:'' [[Entecavir]]&nbsp;•  [[Lamivudine]]&nbsp;•  [[Telbivudine]]&nbsp;•  [[Clevudine]]<BR>
+
| list3 = {{Navbox|child
  
''[[Nucleotide analogue]]s/[[Reverse_transcriptase_inhibitor#Nucleotide_analog_reverse_transcriptase_inhibitors_.28NtARTIs_or_NtRTIs.29|NtRTI]]s:'' [[Adefovir]]&nbsp;•  [[Tenofovir]]
+
  | group1 = Nucleic acid inhibitors
 +
  | list1 =
 +
* [[Cidofovir]]
 +
* [[Brincidofovir]]
  
 +
  | group2 = [[Interferon]]
 +
  | list2 =
 +
* [[Interferon alfa 2b]]
 +
* [[Peginterferon alfa-2a]]
  
| group8 = Multiple/general
+
  | group3 = Multiple/unknown
| list8 = {{Navbox subgroup
+
  | list3 =
| groupstyle = background:PowderBlue;
+
* [[Filociclovir]]<sup>†</sup>
 +
* [[Ribavirin]]<sup>#</sup>/[[Taribavirin]]<sup>'''†'''</sup>
 +
* [[Moroxydine]]
  
| group1 = Nucleic acid inhibitors
+
  }}
| list1 = [[Cidofovir]]
 
  
| group2 = [[Interferon]]
+
| belowstyle = background: transparent; padding: 0px;
| list2  = [[Interferon alfa-2b]]&nbsp;•  [[Peginterferon alfa-2a]]
+
  | below = {{PharmNavFootnote}}
 
 
|group3 = Multiple/unknown
 
|list3  = [[Ribavirin]]<sup>#</sup>/[[Taribavirin]]<sup>'''†'''</sup>
 
 
 
|group4  = ErbB2/PI3K Pathway
 
|list4  = [[NOV-205]]<sup>'''§'''</sup>&nbsp;•  [[NOV-002]]<sup>'''†'''</sup>
 
 
 
 
 
}}
 
 
 
 
 
 
 
below = {{PharmNavFootnote}}<BR>{{Virus navs}}
 
  
 
}}<noinclude>
 
}}<noinclude>
 
+
{{collapsible option}}
[[Category:Drug_templates by ATC|{{PAGENAME}}]]
+
[[Category:Drug templates by ATC]]
 
 
[[fr:Modèle:Antiviral]]
 
[[hu:Sablon:AntivirálisSzerek]]
 
[[th:แม่แบบ:ยาต้านไวรัส]]
 
[[zh:Template:抗DNA病毒药物]]
 
 
</noinclude>
 
</noinclude>

Latest revision as of 14:47, 31 October 2020

Initial visibility: currently defaults to autocollapse

To set this template's initial visibility, the |state= parameter may be used:

  • |state=collapsed: {{DNA antivirals|state=collapsed}} to show the template collapsed, i.e., hidden apart from its title bar
  • |state=expanded: {{DNA antivirals|state=expanded}} to show the template expanded, i.e., fully visible
  • |state=autocollapse: {{DNA antivirals|state=autocollapse}}
    • shows the template collapsed to the title bar if there is a {{navbar}}, a {{sidebar}}, or some other table on the page with the collapsible attribute
    • shows the template in its expanded state if there are no other collapsible items on the page

If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.